Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.

about

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy

P2860

Q55259541-04C5E5DF-0B88-4EC0-A465-A4B46BE05B6B Q57817490-4D752921-3905-41D5-8F75-5B5EB463DC88

P2860

Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q50195636

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pretreatment neutrophil-lympho ...... r in hepatocellular carcinoma.

@en

Pretreatment neutrophil-lympho ...... r in hepatocellular carcinoma.

@nl

type

Item

label

Pretreatment neutrophil-lympho ...... r in hepatocellular carcinoma.

@en

Pretreatment neutrophil-lympho ...... r in hepatocellular carcinoma.

@nl

prefLabel

Pretreatment neutrophil-lympho ...... r in hepatocellular carcinoma.

@en

Pretreatment neutrophil-lympho ...... r in hepatocellular carcinoma.

@nl

P1476

Pretreatment neutrophil-lympho ...... r in hepatocellular carcinoma.

@en

P2093

Jean C Emond

http://www.w3.org/2001/XMLSchema#string

Karim J Halazun

http://www.w3.org/2001/XMLSchema#string

Marc Najjar

http://www.w3.org/2001/XMLSchema#string

Surbhi Agrawal

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.

A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

P304

17-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JHC.S86792

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29404284

http://www.w3.org/2001/XMLSchema#string

P932

5779314

http://www.w3.org/2001/XMLSchema#string

Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.

about

P2860

P2860

Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932